FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/04/2024
Voltar para busca
Dado oficial do USPTO
ALPHINIA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
29/04/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
20/05/2022
Data de registro
09/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/01/2024
Última transação
09/01/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
82
Localização do titular
AU
Examinador
STRUCK, ROBERT J
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Alphinia Pty Ltd
Representantes
Jennifer A. Visintine Thompson Coburn LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Advisory services relating to immunological product development; benchmarkingtechnical testing in the field of geneticsbiologybiotechnologymicrobiologybiochemistry and pharmacy for scientific and medical research purposes; biological research; biotechnological research; biotechnology testing for scientific research purposes; conducting statistical scientific studies in the field of geneticsbiologybiotechnologymicrobiologybiochemistry and pharmacy; development of new products; development of new products for medical purposesmedicinespharmaceuticalstherapeutic and immunological products; development and testing of chemical production methods; dna testing services for scientific research purposes; genetic testing for scientific research purposes; genetic researchmammalian genetics research; scientific research in the field of genetics; laboratory testing servicesscientific laboratory services; medical laboratory services; laboratory testing services for othersscientific research and analysis in the field of geneticsbiologybiotechnologymicrobiologybiochemistry and pharmacy; microbiological testing for scientific research purposes; preparation of scientific reportsscientific research in the field of geneticsbiologybiotechnologymicrobiologybiochemistry and pharmacy; advisory services relating to product testing; product testing; provision of scientific information in the field of geneticsbiologybiotechnologymicrobiologybiochemistry and pharmacy; scientific research advisory services for others; scientific advisory services for others in the field of geneticsbiologybiotechnologymicrobiologybiochemistry and pharmacy; scientific and technical analysisscientific research consulting in the field of geneticsbiologybiotechnologymicrobiologybiochemistry and pharmacy; scientific and technological servicesscientific researchanalysistesting and development in the field of geneticsbiologybiotechnologymicrobiologybiochemistry and pharmacy; scientific research consulting; scientific laboratory services; analysis of statistical data for scientific research; medical and scientific researchconducting clinical trials for others; medical researchscientific research for medical purposes; scientific and technological research for medical purposes in the field of geneticsbiologybiotechnologymicrobiologybiochemistry and pharmacy; advisory services relating to scientific research; scientific research and development services in the field of protein bioengineering; advisory services relating to technological research for use in the development of new medicinespharmaceuticalsimmunological productstherapeutic goods; scientific and technological research relating to patent mapping; technological research in the field of geneticsbiologybiotechnologymicrobiologybiochemistry and pharmacy
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/04/2024
FIMP
FINAL DISPOSITION PROCESSED
10/04/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/04/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
21/01/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/01/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/01/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/01/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/01/2024
GPNX
NOTIFICATION PROCESSED BY IB
24/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/10/2023
PUBO
PUBLISHED FOR OPPOSITION
24/10/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/10/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/08/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/07/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/07/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/07/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/07/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/07/2023
RFNP
REFUSAL PROCESSED BY IB
24/05/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/05/2023
RFRR
REFUSAL PROCESSED BY MPU
02/05/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/03/2023
CNRT
NON-FINAL ACTION WRITTEN
13/03/2023
DOCK
ASSIGNED TO EXAMINER
10/03/2023
MAFR
APPLICATION FILING RECEIPT MAILED
05/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/08/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
28/07/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/07/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ALPHINIA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.